Iovance Biotherapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
IOVA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
825 Industrial Road, 4 Th Floor, San Carlos, California

Insiders trading volume in the past year

Iovance Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Wayne P. Rothbaum Director $258M +$72.3M +39% Mar 1, 2024
Merrill A. Mcpeak Director $5.66M +$2.34M +70.6% Mar 1, 2024
Frederick G. Vogt Interim CEO & General Counsel, Director $2.59M Sep 3, 2024
Iain Dukes Director $1.32M +$293K +28.5% Jun 11, 2024
Friedrich Graf Chief Medical Officer $898K Sep 3, 2024
Igor Bilinsky Chief Operating Officer $845K Sep 3, 2024
Jean-Marc Bellemin Chief Financial Officer $522K Sep 3, 2024
Wendy L. Dixon Director $469K Jun 10, 2022
Wendy L. Yarno Director $413K Jun 11, 2024
Ryan Maynard Director $413K Jun 11, 2024
Michael Weiser Director $413K Jun 11, 2024
Athena Countouriotis Director $413K Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for Iovance Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.